Ann: ResApp Successfully Completes $7.5 Million Capital Raising, page-7

Roger Aston "... high level of oversubscription we received is a testament to our progress and to the stellar potential in our future." CR will be used, among other things, to immediately begin double-blind study on adults to complete forthcoming US winter... and thereby accelerate FDA approval(s). Stellar future indeed if the current US paediatric results are at least as strong as Aus SC-C2 results. GLTAH R-7